Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Cathelicidin Antimicrobial Peptide
LL-37 is the active fragment of the human cathelicidin antimicrobial peptide, studied in research for antimicrobial and immunomodulatory activity.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
LL-37 is the active fragment of the human cathelicidin antimicrobial peptide, studied in research for antimicrobial and immunomodulatory activity.
Experimental models examine its membrane interactions and pleiotropic signaling under controlled laboratory conditions.
Third-party tested for purity, ID, quantity.
LL-37 is a 37-residue amphipathic peptide derived from the cathelicidin precursor hCAP18. Research has characterized its direct antimicrobial action alongside pleiotropic host-defense roles, including immunomodulation, angiogenesis, and wound-repair signaling.
Studies span antimicrobial, sepsis, and cardiovascular research models under structured conditions.
LL-37 was identified as the proteolytically released active fragment of human cathelicidin, the only cathelicidin expressed in humans.
Research has since characterized its broad antimicrobial spectrum and its expanding roles in innate immunity and tissue repair.
Research into LL-37 focuses on antimicrobial and host-defense signaling. Frameworks evaluate membrane-disruption mechanisms, immunomodulation, and tissue-repair endpoints under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of ll 37. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
PubMedTherapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
PubMedCathelicidin peptide LL-37: A multifunctional peptide involved in heart disease
PubMedRelated
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$80.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
